We are live on ! Find out more
DERM

Dermira, Inc.
DERM

Delisted

DERM was delisted on the 19th of February, 2020.

121 hedge funds and large institutions have $1.18B invested in Dermira, Inc. in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 55 increasing their positions, 34 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

729% more call options, than puts

Call options by funds: $2.75M | Put options by funds: $332K

62% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0% less capital invested

Capital invested by funds: $1.19B → $1.18B (-$2.36M)

10% less funds holding

Funds holding: 134121 (-13)

41% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 27

Holders
121
Holders Change
-13
Holders Change %
-9.7%
% of All Funds
3.02%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
16
Increased
55
Reduced
34
Closed
27
Calls
$2.75M
Puts
$332K
Net Calls
+$2.42M
Net Calls Change
+$375K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$9.3M +$5.91M +194,503 +156%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$8.93M +$1.65M +54,188 +21%
GC
28
Guggenheim Capital
Illinois
$7.38M +$2.59M +85,213 +51%
JP Morgan Chase
29
JP Morgan Chase
New York
$6.96M +$6.33M +208,105 +679%
Axa
30
Axa
France
$6.18M
Renaissance Technologies
31
Renaissance Technologies
New York
$5.78M +$5.12M +168,300 +561%
CCP
32
Clough Capital Partners
Massachusetts
$5.3M -$2.22M -73,000 -29%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$5.24M -$606K -19,921 -10%
CM
34
Castleark Management
Illinois
$5.17M -$66K -2,172 -1%
FCMI
35
Foresite Capital Management III
California
$5.13M
CAM
36
Cormorant Asset Management
Massachusetts
$4.95M
SEI Investments
37
SEI Investments
Pennsylvania
$4.95M +$201K +6,616 +4%
Charles Schwab
38
Charles Schwab
California
$4.09M +$829K +27,259 +24%
IHM
39
Iguana Healthcare Management
New York
$4.08M
Goldman Sachs
40
Goldman Sachs
New York
$4M -$288K -9,488 -6%
FCMI
41
Foresite Capital Management II
California
$3.94M -$1.52M -50,000 -27%
IBT
42
International Biotechnology Trust
United Kingdom
$3.76M +$730K +24,000 +23%
NIP
43
Nicholas Investment Partners
California
$3.7M +$626K +20,587 +19%
Bank of America
44
Bank of America
North Carolina
$3.7M -$587K -19,305 -13%
EAM
45
Eventide Asset Management
Massachusetts
$3.61M +$3.77M +124,000 New
CWG
46
C WorldWide Group
Denmark
$3.52M +$1.16M +38,069 +46%
NC
47
Nexthera Capital
New York
$3.51M +$3.67M +120,600 New
TCIM
48
TIAA CREF Investment Management
New York
$2.98M -$264K -8,689 -8%
PC
49
Polar Capital
United Kingdom
$2.91M
Point72 Asset Management
50
Point72 Asset Management
Connecticut
$2.88M +$911K +29,983 +44%

DERM Hedge Fund Activity: Q2 2017 in Review

121 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Dermira, Inc. (DERM) for Q2 2017, worth a combined $1.18B — down 0.2% from $1.19B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of DERM and 16 opened new positions — a net loss of 11 holders — while 34 trimmed existing stakes and 55 added.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $91.2M. The largest seller was Fidelity Investments, cutting an estimated $15.1M.

  • 121 institutional investors held Dermira, Inc. (DERM) as of Q2 2017, down from 134 in Q1 2017.
  • Funds reported $1.18B of Dermira, Inc. stock for Q2 2017, down 0.2% quarter-over-quarter.
  • 16 funds opened new Dermira, Inc. positions in Q2 2017 and 27 closed out, a net change of -11 holders.
  • The largest Dermira, Inc. buyer in Q2 2017 was Wellington Management Group, an estimated $91.2M added.
  • The largest Dermira, Inc. seller in Q2 2017 was Fidelity Investments, an estimated $15.1M sold.

Based on aggregated 13F filings for Q2 2017.